COCCO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 466
EU - Europa 343
AS - Asia 253
SA - Sud America 21
AF - Africa 1
Totale 1.084
Nazione #
US - Stati Uniti d'America 461
GB - Regno Unito 137
CN - Cina 118
SG - Singapore 87
SE - Svezia 53
FR - Francia 30
HK - Hong Kong 27
DE - Germania 25
IE - Irlanda 25
RU - Federazione Russa 24
BR - Brasile 19
FI - Finlandia 19
IT - Italia 13
KR - Corea 8
UA - Ucraina 7
CA - Canada 4
VN - Vietnam 4
BD - Bangladesh 3
BE - Belgio 3
AT - Austria 2
PL - Polonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CO - Colombia 1
ES - Italia 1
IN - India 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
NL - Olanda 1
ZA - Sudafrica 1
Totale 1.084
Città #
Southend 108
Chandler 83
Jacksonville 56
Houston 47
Singapore 47
Ann Arbor 35
Hong Kong 27
Ashburn 26
Dublin 25
Woodbridge 25
Beijing 23
Dallas 22
Lancaster 12
Lawrence 11
Princeton 11
Jinan 9
Nanjing 9
Wilmington 9
Seoul 8
Columbus 7
Hebei 7
Helsinki 7
Boardman 6
Detroit 6
Munich 6
Nanchang 6
Santa Clara 6
Tianjin 6
Jiaxing 5
New York 5
Verona 5
Taiyuan 4
Atlanta 3
Brussels 3
Cascia 3
Dearborn 3
Guangzhou 3
Leipzig 3
Zhengzhou 3
Chicago 2
Fuzhou 2
Haikou 2
Hangzhou 2
Ho Chi Minh City 2
Los Angeles 2
Naples 2
North Bergen 2
Nuremberg 2
Phoenix 2
Seattle 2
Shenyang 2
The Dalles 2
Toronto 2
Amman 1
Anápolis 1
Aquiraz 1
Auburn Hills 1
Bilgi 1
Boston 1
Brooklyn 1
Buffalo 1
Bình An 1
Calgary 1
Cambé 1
Changsha 1
Chaoyang 1
City of London 1
Clearwater 1
Cleveland 1
Colatina 1
Cormons 1
Cotia 1
Council Bluffs 1
Cuddalore 1
Curitiba 1
Dhaka 1
Dubai 1
Edinburgh 1
Esteio 1
Fairfield 1
Falkenstein 1
Frankfurt am Main 1
Fushan 1
Hanoi 1
Hyattsville 1
Iaciara 1
Istanbul 1
Johannesburg 1
Kemerovo 1
Kent 1
Kingston 1
Lanzhou 1
London 1
Manchester 1
Moscow 1
Nova Friburgo 1
Paracatu 1
Pasto 1
Paulista 1
Porto Velho 1
Totale 765
Nome #
Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy 131
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 113
Investigative clinical study on prostate cancer part VIII: prolactin hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy. 111
Investigative clinical study on prostate cancer Part V: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 107
Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 103
Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 91
Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy 91
DEFINITION OF UPPER REFERENCE LIMIT FOR THYROID PEROXIDASE AUTOANTIBODIES ACCORDING TO NACB GUIDELINES: COMPARISON OF SEVEN DIFFERENT AUTOMATED METHODS. Part B (in : Reference ranges, standardization and decision levels) 89
Choosing wisely: la lista del gruppo di studio Endocrinologia e Malattie del Metabolismo della Società Italiana di Patologia Clinica e Medicina di Laboratorio 88
DEFINITION OF UPPER REFERENCE LIMIT FOR THYROID PEROXIDASE AUTOANTIBODIES ACCORDING TO NACB GUIDELINES: COMPARISON OF FIVE DIFFERENT AUTOMATED METHODS. PART A (in Reference ranges, standardization and decision levels) 88
Role of CA 15-3 to guide therapy in metastatic breast cancer [Il ruolo di CA 15-3 nel monitoraggio della terapia nel carcinoma mammario metastatico] 85
Totale 1.097
Categoria #
all - tutte 4.393
article - articoli 3.667
book - libri 0
conference - conferenze 726
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 7 9 6 10 2 5 0 1 9 3
2021/2022118 12 36 0 23 0 7 2 6 2 2 4 24
2022/2023196 20 17 23 26 20 41 3 17 16 1 8 4
2023/202497 4 14 9 5 16 15 1 7 0 11 10 5
2024/2025194 9 18 15 33 5 13 2 4 24 11 18 42
2025/202685 54 23 8 0 0 0 0 0 0 0 0 0
Totale 1.097